LRP4 and myasthenia gravis: The pathogenic antibodies in MG include antibodies against the acetylcholine receptor (anti-AChR), muscle-specific kinase (anti-MuSK), and low-density lipoprotein receptor-related protein 4 (anti-LRP4).